Dupont Capital Management’s Cytokinetics CYTK Stock Holding History

Dupont Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,922	Closed	-$323K	–	1321
2020 Q3	$323K	Sell	14,922 -1,000	-6%	-$23.4K	0.01%	950
2020 Q2	$375K	Sell	15,922 -6,994	-31%	-$131K	0.01%	894
2020 Q1	$270K	Buy	+22,916	New	+$292K	0.01%	907
2017 Q4	–	Sell	-22,940	Closed	-$333K	–	944
2017 Q3	$333K	Hold	22,940	–	–	0.01%	747
2017 Q2	$278K	Buy	+22,940	New	+$319K	0.01%	779
2016 Q1	–	Sell	-28,633	Closed	-$300K	–	641
2015 Q4	$300K	Buy	+28,633	New	+$281K	0.01%	620

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Dupont Capital Management's CYTK Position: Q4 2020 in Review

Dupont Capital Management sold out of Cytokinetics (CYTK) in Q4 2020, closing a stake of 14,922 shares — an estimated $323K sold.

Dupont Capital Management first reported a position in CYTK in Q4 2015 and held it in 6 quarters. The position peaked at $375K in Q2 2020. 178 funds tracked by Wall St. Rank hold CYTK as of Q4 2020.

Dupont Capital Management reported no remaining Cytokinetics position as of Q4 2020 after selling out during the quarter.
Dupont Capital Management sold 14,922 Cytokinetics shares in Q4 2020, an estimated $323K.
Dupont Capital Management first reported a position in Cytokinetics in Q4 2015 and held it in 6 quarters.
Dupont Capital Management's Cytokinetics position peaked at $375K in Q2 2020.
178 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2020.

Based on Dupont Capital Management's 13F filing for Q4 2020, filed 28 Jan 2021.